EGBN(EGBN)
EGBN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $300M | $305M | $287M |
| Low | $290M | $277M | $271M |
| High | $307M | $326M | $298M |
| EBITDA Avg | $56M | $57M | $53M |
| Low | $54M | $52M | $50M |
| High | $57M | $61M | $55M |
| EBIT Avg | $54M | $55M | $51M |
| Low | $52M | $50M | $49M |
| High | $55M | $58M | $53M |
| Net Income Avg | $53M | $78M | $112M |
| Low | $43M | $56M | $105M |
| High | $55M | $82M | $119M |
| EPS Avg | $1.63 | $2.43 | $3.75 |
| Low | $1.41 | $1.85 | $3.48 |
| High | $1.82 | $2.72 | $3.94 |
| Analysts (Rev / EPS) | 3 / 3 | 4 / 3 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $74M | $75M | $74M | $76M | $77M | $78M |
| Low | $71M | $70M | $70M | $71M | $72M | $73M |
| High | $77M | $80M | $78M | $79M | $81M | $81M |
| EBITDA Avg | $14M | $14M | $14M | $14M | $14M | $14M |
| Low | $13M | $13M | $13M | $13M | $13M | $14M |
| High | $14M | $15M | $15M | $15M | $15M | $15M |
| EBIT Avg | $13M | $14M | $13M | $14M | $14M | $14M |
| Low | $13M | $13M | $13M | $13M | $13M | $13M |
| High | $14M | $14M | $14M | $14M | $14M | $15M |
| Net Income Avg | $12M | $14M | $16M | $18M | $20M | $20M |
| Low | $10M | $11M | $15M | $17M | $18M | $18M |
| High | $14M | $16M | $17M | $19M | $21M | $21M |
| EPS Avg | $0.39 | $0.46 | $0.52 | $0.59 | $0.64 | $0.65 |
| Low | $0.33 | $0.35 | $0.48 | $0.54 | $0.59 | $0.59 |
| High | $0.45 | $0.51 | $0.55 | $0.62 | $0.68 | $0.68 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |